Ge Long Hui·2025-09-06 02:24Summary of Key Points Core Viewpoint - Multiple shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership dynamics and investor sentiment in the A-share market [1]. Shareholder Reductions - Tonghuashun's controlling shareholder Yi Zheng and shareholder Kaishun plan to reduce their holdings by no more than 1.3831 million shares [1]. - Liren Technology's actual controller's concerted actor, Liren Investment, intends to reduce its stake by no more than 3% [1]. - Kaipu Detection's deputy general managers Wang Wei and Song Xia plan to collectively reduce their holdings by no more than 0.67% [1]. - Chery Technology intends to reduce its stake in Ruimuju by no more than 3% [1]. - Aohai Technology's shareholder Jian Aoyue plans to reduce its stake by no more than 2.57% [1]. - Lianhong Xinke's shareholder Lianhong Sheng intends to reduce its stake by no more than 0.78% [1]. - Changjiang Materials' controlling shareholder and actual controller Xiong Ying plans to reduce his stake by no more than 3% [1]. - Jiejia Weichuang's shareholder Li Shijun plans to reduce his stake by no more than 0.8649% [1]. - Jialian Technology's shareholders Zhenhai Jinshu and Zhenhai Jinmo plan to collectively reduce their holdings by no more than 2.6166% [1]. - Chengda Pharmaceutical's shareholder Qianhai Shengtai intends to reduce its stake by no more than 7.27% [1]. - Keta Bio's shareholder Ningbo Shunyi plans to reduce its holdings by no more than 790,480 shares [1]. - Huawu shares' controlling shareholder and its concerted actors plan to reduce their holdings by no more than 3% [1]. - Bid Pharmaceutical's shareholders Zhoushan Xinxie and Ningbo Landan plan to collectively reduce their holdings by no more than 2.86% [1]. Other Notable Events - *ST Zitian has received a decision for stock delisting [1]. - ST Lingnan and its former controlling shareholder have received a notice of investigation from the China Securities Regulatory Commission [1].